伊索尼亚兹的历史发展,与代谢相关的毒性以及对其药理学改进的观点
Jishnu Sankar1, Anjali Chauhan1,2, Ramandeep Singh3
1Centre for Drug Discovery, BRIC-Translational Health Science and Technology Institute, Faridabad, Haryana, India.
Frontiers in pharmacology
|October 4, 2024
概括
异化 (INH) 对结核病有效,但由于其代谢导致肝损伤和神经问题. 使用可水解衍生物的新方法可能会减少这些有毒副作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 药用化学 医学化学
背景情况:
- 异化 (INH) 是一种重要的抗结核药物.
- INH导致显著的肝毒性和外围神经病变.
- INH的末端-NH2组的新陈代谢与毒性有关.
研究的目的:
- 审查INH的病史,机制和临床试验.
- 详细介绍INH代谢及其与不良事件的关联.
- 提出一种新的方法来减轻INH毒性.
主要方法:
- 关于INH起源,作用和临床试验的文献综述.
- 涉及INH和宿主酶 (例如NAT-2) 的代谢途径的分析.
- 检查临床研究中的不良事件数据.
主要成果:
- 通过INH代谢,特别是通过终端-NH2组,产生有毒代谢物.
- N-乙转移酶-2 (NAT-2) 在INH生物转化中发挥着关键作用.
- 肝毒性影响10~20%的患者,神经病变影响2~6.5%,致命性肝炎影响0.05-1%.
结论:
- INH的终端-NH2组是其毒性的核心.
- 了解代谢途径是管理INH副作用的关键.
- 可水解化学衍生物为减少INH诱导的毒性提供了一个有希望的策略.
更多相关视频
相关概念视频
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
151
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
151
Phase II Reactions: Acetylation Reactions
193
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
193
Phase I Oxidative Reactions: Overview
246
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
246
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Drug Metabolism: Phase I Reactions
3.2K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.2K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
195
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
195


